Bora Pharmaceuticals : To announce in accordance with Article 25.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies
To announce in accordance with Article 25.1(3) of
the Regulations Governing Loaning of Funds and Making
of Endorsements/Guarantees by Public Companies
Date of events
2022/04/11
To which item it meets
paragraph 22
Statement
1.Date of occurrence of the event:2022/04/11
2.For the company for whom the endorsements
/guarantees were made(1)Company name(2)Its
relationship with the Company providing endorsements/
guarantees(3)The ceiling on the endorsements/
guarantees (thousand NTD)(4)The original amount of
endorsements/guarantees (thousand NTD)(5)he amount
of the current additional endorsements/guarantees
(thousand NTD)(6)The amount of endorsements/guarantees
as of the dateof occurrence (thousand NTD)(7)The actual
loaned amount of the company for whom endorsements/
guarantees were made (thousand NTD)(8)The reason for
the current additional endorsements/guarantees:
1
(1)Company name: Bora Pharmaceutical Laboratories Inc.
(2)Its relationship with the Company providing
endorsements/guarantees: 100% owned subsidiary
(3)The ceiling on the endorsements/guarantees (thousand NTD):
15,762,705
(4)The original amount of endorsements/guarantees
(thousand NTD): 567,500
(5)The amount of the current additional endorsements/
guarantees (thousand NTD): 370,000
(6)The amount of endorsements/guarantees as of the
date of occurrence (thousand NTD): 937,500
(7)The actual loaned amount of the company for whom
endorsements/guarantees were made (thousand NTD): 168,000
(8)The reason for the current additional endorsements/
guarantees: Guarantee for bank financing
2
(1)Company name: Bora Health Inc.
(2)Its relationship with the Company providing
endorsements/guarantees: 100% owned subsidiary
(3)The ceiling on the endorsements/guarantees (thousand NTD):
15,762,705
(4)The original amount of endorsements/guarantees
(thousand NTD): 225,000
(5)The amount of the current additional endorsements/
guarantees (thousand NTD): 30,000
(6)The amount of endorsements/guarantees as of the
date of occurrence (thousand NTD): 255,000
(7)The actual loaned amount of the company for whom
endorsements/guarantees were made (thousand NTD): 86,298
(8)The reason for the current additional endorsements/
guarantees: Guarantee for bank financing
3.For collaterals provided by the company for
whom the endorsements/guarantees were made, the
(1)Content(2)Value (thousand NTD): Not applicable
4.For the latest financial statements of the company
for whom the endorsements/guarantees were made, the
(1)Capital (thousand NTD)(2)Cumulative gains/losses
(thousand NTD):
(1)Capital(thousand NTD):1,330,000
(2)Cumulative gain (thousand NTD):57,872
5.For termination of endorsement/guarantee obligations, the
(1)Condition(2)Date: In accordance with the contract
(1)Condition:In accordance with the contract
(2)Date:In accordance with the contract
6.The total amount of the ceiling on endorsements/
guarantees (thousand NTD):15,762,705
7.The total amount of endorsements/guarantees as of
the date of occurrence (thousand NTD):7,422,750
8.The amount of endorsements/guarantees provided by
A as a percentage of the public company's net worth
on the latest financial report as of the date of
occurrence:235.45
9.The aggregate amount of long-term investments,
endorsements/guarantees, and monetary loans extended
to others as a percentage of the public company's net
worth on the latest financial statements:342.61
10.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bora Pharmaceuticals Co. Ltd. published this content on 11 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2022 16:00:31 UTC.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
Bora Pharmaceuticals : To announce in accordance with Article 25.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies
BORA PHARMACEUTICALS CO., LTD. 
